Exelixis | EXEL - Batas Pemasukan





Batas Pemasukan Perubahan Tanggal
Acadia Pharmaceuticals USD 53.52M 22.02M 2026-09
Agios Pharmaceuticals USD -100.7M 1.59M 2026-06
Akebia Therapeutics USD -12.24M 12.78M 2025-12
Amgen USD 3.86B 1.49B 2026-09
AstraZeneca USD 3.12B 610M 2026-09
Bayer EUR -672M 891M 2026-09
BioMarin Pharmaceutical USD -122.83M 167.59M 2026-09
Bristol-Myers Squibb USD 2.16B 1.16B 2026-09
Cytokinetics USD -190.07M 8.69M 2026-09
Eisai JPY 18.24B 21.49B 2026-06
Eli Lilly USD 7.1B 301M 2026-06
Exelixis USD 218.1M 6.04M 2026-09
Genmab DKK 303M 250M 2026-06
Glaxosmithkline GBP 1.54B 194M 2026-09
Incyte USD -784.8M 1.37B 2026-09
Ionis Pharmaceuticals USD -114.65M 21.65M 2026-06
MacroGenics USD 19.52M 56.29M 2026-06
Merck USD 5.07B 6.4B 2026-09
Moderna USD 162M 944M 2026-09
Nektar Therapeutics USD -44.9M 8.82M 2026-03
Neurocrine Biosciences USD 144.4M 53.5M 2026-06
Novartis USD 1.2B 2.06B 2026-09
Pfizer USD 3.24B 3.49B 2026-09
Puma Biotechnology USD 20.32M 24.85M 2024-09
Sanofi EUR 343M 1.27B 2026-06
Takeda JPY 192.43B 79.23B 2026-09
Ultragenyx Pharmaceutical USD -118M 26M 2026-09
Xencor USD -21.73M 107.19M 2026-06